These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 15944267)

  • 1. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor.
    Cao J; Papadopoulou N; Kempuraj D; Boucher WS; Sugimoto K; Cetrulo CL; Theoharides TC
    J Immunol; 2005 Jun; 174(12):7665-75. PubMed ID: 15944267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway.
    Cao J; Cetrulo CL; Theoharides TC
    Mol Pharmacol; 2006 Mar; 69(3):998-1006. PubMed ID: 16332989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells.
    Papadopoulou NG; Oleson L; Kempuraj D; Donelan J; Cetrulo CL; Theoharides TC
    J Mol Endocrinol; 2005 Dec; 35(3):R1-8. PubMed ID: 16326828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells.
    Asadi S; Alysandratos KD; Angelidou A; Miniati A; Sismanopoulos N; Vasiadi M; Zhang B; Kalogeromitros D; Theoharides TC
    J Invest Dermatol; 2012 Feb; 132(2):324-9. PubMed ID: 22089831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing hormone-receptor 2 is required for acute stress-induced bladder vascular permeability and release of vascular endothelial growth factor.
    Boucher W; Kempuraj D; Michaelian M; Theoharides TC
    BJU Int; 2010 Nov; 106(9):1394-9. PubMed ID: 20201838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1 alpha corticotropin-releasing hormone receptor.
    McEvoy AN; Bresnihan B; FitzGerald O; Murphy EP
    Arthritis Rheum; 2001 Aug; 44(8):1761-7. PubMed ID: 11508426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells.
    Kempuraj D; Papadopoulou NG; Lytinas M; Huang M; Kandere-Grzybowska K; Madhappan B; Boucher W; Christodoulou S; Athanassiou A; Theoharides TC
    Endocrinology; 2004 Jan; 145(1):43-8. PubMed ID: 14576187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors.
    Cantarella G; Lempereur L; Lombardo G; Chiarenza A; Pafumi C; Zappalà G; Bernardini R
    Br J Pharmacol; 2001 Oct; 134(4):837-44. PubMed ID: 11606324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function.
    Willenberg HS; Bornstein SR; Hiroi N; Päth G; Goretzki PE; Scherbaum WA; Chrousos GP
    Mol Psychiatry; 2000 Mar; 5(2):137-41. PubMed ID: 10822340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing hormone stimulates SGK-1 kinase expression in cultured hippocampal neurons via CRH-R1.
    Sheng H; Sun T; Cong B; He P; Zhang Y; Yan J; Lu C; Ni X
    Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E938-46. PubMed ID: 18713960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotensin and CRH interactions augment human mast cell activation.
    Alysandratos KD; Asadi S; Angelidou A; Zhang B; Sismanopoulos N; Yang H; Critchfield A; Theoharides TC
    PLoS One; 2012; 7(11):e48934. PubMed ID: 23155429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells.
    Abdel-Majid RM; Marshall JS
    J Immunol; 2004 Jan; 172(2):1227-36. PubMed ID: 14707101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional expression of corticotropin-releasing hormone (CRH) receptor 1 in cultured rat microglia.
    Wang W; Ji P; Riopelle RJ; Dow KE
    J Neurochem; 2002 Jan; 80(2):287-94. PubMed ID: 11902119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing hormone attenuates vascular endothelial growth factor release from human HaCaT keratinocytes.
    Zhou CL; Yu XJ; Chen LM; Jiang H; Li CY
    Regul Pept; 2010 Feb; 160(1-3):115-20. PubMed ID: 19852986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of corticotropin-releasing factor receptor type 2beta mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells.
    Kageyama K; Gaudriault GE; Suda T; Vale WW
    Cell Signal; 2003 Jan; 15(1):17-25. PubMed ID: 12401516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing hormone signaling in synovial tissue vascular endothelium is mediated through the cAMP/CREB pathway.
    McEvoy AN; Bresnihan B; Fitzgerald O; Murphy EP
    Ann N Y Acad Sci; 2002 Jun; 966():119-30. PubMed ID: 12114266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a New Exo-Endocytic Mechanism Triggered by Corticotropin-Releasing Hormone in Mast Cells.
    Balseiro-Gomez S; Flores JA; Acosta J; Ramirez-Ponce MP; Ales E
    J Immunol; 2015 Sep; 195(5):2046-56. PubMed ID: 26202981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins.
    Grammatopoulos DK; Randeva HS; Levine MA; Katsanou ES; Hillhouse EW
    Mol Endocrinol; 2000 Dec; 14(12):2076-91. PubMed ID: 11117536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.
    Singh LK; Boucher W; Pang X; Letourneau R; Seretakis D; Green M; Theoharides TC
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1349-56. PubMed ID: 10027877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential responses of corticotropin-releasing hormone receptor type 1 variants to protein kinase C phosphorylation.
    Markovic D; Papadopoulou N; Teli T; Randeva H; Levine MA; Hillhouse EW; Grammatopoulos DK
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1032-42. PubMed ID: 16956982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.